The era of GWAS is over

Abstract

Get full access to this article

View all access options for this article.

References

International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N Eng J Med 2007; 357: 851–862.

Oksenberg

JR.

Decoding multiple sclerosis: An update on genomics and future directions. Expert Rev Neurother 2013; 13: 11–19.

International Multiple Sclerosis Genetics Consortium. The multiple sclerosis genomic map: Role of peripheral immune cells and resident microglia in susceptibility, http://www.biorxiv.org/content/early/2017/07/13/143933

Visscher

Wray

Zhang

et al . 10 years of GWAS discovery: Biology, function, and translation. Am J Hum Genet 2017; 101: 5–22.

Shearer

Suzuki

et al . Genetic-epigenetic interactions in cis: A major focus in the post-GWAS era. Genome Biol 2017; 18: 120.

Edwards

Beesley

French

et al . Beyond GWASs: Illuminating the dark road from association to function. Am J Hum Genet 2013; 93: 779–797.

Lopez

Lapuente

Feliú

Ugidos

et al . Novel insights into the multiple sclerosis risk gene ANKRD55. J Immunol 2016; 196: 4553–4565.

Struck

Mannakee

Gutenkunst

. How much research is spurred when a gene is associated with a complex disease, https://www.biorxiv.org/content/biorxiv/early/2017/02/07/106773.full.pdf

Lündstrom

Highfill

Walsh

STR

et al . Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity. Proc Natl Acad Sci U S A 2013; 110: E1761–E1770.

10.

Galarza-Muñoz

Briggs

FBS

Evsyukova

et al . Human epistatic interaction controls IL7R splicing and increases multiple sclerosis risk. Cell 2017; 169: 72–84.

The era of GWAS is over – Yes

Abstract

Get full access to this article

References